During the FDA's December 11, 2020, emergency use authorization meeting for the Pfizer Covid-19 mRNA vaccines, FDA committee members pointed out that the mRNA vaccines appear to provide no clinical benefit, specifically regarding severe disease.
During the FDA's December 11, 2020, emergency use authorization meeting for the Pfizer Covid-19 mRNA vaccines, FDA committee members pointed out that the mRNA vaccines appear to provide no clinical benefit, specifically regarding severe disease.